Urology Qdata^®- Transforming Structured And Unstructured Data

Verana Health^® advances urologic research by transforming real-world clinical data into actionable insights that support every phase of the drug development lifecycle. Through its exclusive partnership with the American Urological Association (AUA), Verana curates data from the AUA Quality Registry (AQUA), encompassing over 13 million de-identified patients, 111 million patient encounters, and a decade of longitudinal data from more than 2,300 clinicians.

The platform ingests both structured and unstructured EHR data—particularly rich in clinician notes—then de-identifies, links, and curates this information using natural language processing (NLP), machine learning (ML), and expert clinical oversight. The result is Verana’s Qdata^®: high-quality, fit-for-purpose data modules tailored to conditions such as prostate cancer, benign prostatic hyperplasia (BPH), non-muscle invasive bladder cancer (NMIBC), and more, with additional modules like erectile dysfunction and overactive bladder in development. These insights support a wide range of research and commercial needs, including trial design and recruitment, burden of disease assessments, pricing strategies, market forecasting, and post-approval safety and effectiveness studies.

These insights support a wide range of research and commercial needs, including trial design and recruitment, burden of disease assessments, pricing strategies, market forecasting, and post-approval safety and effectiveness studies. Verana Health’s data-driven approach empowers life sciences companies to make informed decisions, accelerate clinical trials, and improve patient outcomes across the urologic care spectrum.